These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25231972)

  • 1. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
    Song A; Su Z; Li S; Han F
    Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen.
    Han F; Li S; Yin R; Shi X; Jia Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):453-8. PubMed ID: 18401788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of l-menthol-ethanol-water system on the systemic absorption of flurbiprofen after repeated topical applications in rabbits.
    Morimoto Y; Hayashi T; Kawabata S; Seki T; Sugibayashi K
    Biol Pharm Bull; 2000 Oct; 23(10):1254-7. PubMed ID: 11041263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of galangal essential oil-based microemulsion gel for transdermal delivery of flurbiprofen: simultaneous permeability evaluation of flurbiprofen and 1,8-cineole.
    Dong J; Zhu XM; Wu FY; Yang BQ; Feng H; Dong YF; Gu W; Chen J
    Drug Dev Ind Pharm; 2020 Jan; 46(1):91-100. PubMed ID: 31878816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rabbit ear flap perfusion experiment to evaluate the percutaneous absorption of drugs.
    Seki T; Hosoya O; Yamazaki T; Sato T; Saso Y; Juni K; Morimoto K
    Int J Pharm; 2004 May; 276(1-2):29-40. PubMed ID: 15113611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
    Rajinikanth PS; Chellian J
    Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
    Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
    J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.
    Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM
    Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation.
    Yılmaz Usta D; Teksin ZS; Tugcu-Demiroz F
    AAPS PharmSciTech; 2024 May; 25(5):124. PubMed ID: 38822143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
    Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
    Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.